Campbell David Alan sold JANX
January 2, 2026 · Form 4 insider transaction
Campbell David Alan sold 8,072 shares of Janux Therapeutics, Inc. at $13.73 per share, a transaction worth $110.8K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,072
Price
$13.73
Total value
$110.8K
InsiderCampbell David Alan
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 2, 2026
Filing dateJanuary 2, 2026
Shares owned after284,982
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were automatically sold to cover tax withholding obligations associated with the vesting of restricted stock units.